Following a successful presentation at the Cell Therapy Manufacturing and Gene Therapy Congress in Brussels, Onyx has again had a strong presence at the prestigious World Orphan Drugs Congress in Washington. This emphasises Onyx strong and continuing commitment to the areas of orphan drugs, rare and ultra-rare diseases and regenerative medicine including cell and gene therapies.
Associate Consultant in Market Access, Jack Said, talks to us about what his job actually involves and what led him to this role at Prime Global.read more >>
Prime Global announces launch of new technical and strategic communications consultancy, Prime OmicsPrime Global 9 March, 2021
Prime Global, the international medical communications and market access group, today announced the launch of a new technical and strategic communications consultancy, Prime Omics. Prime Omics will support the decoding of molecular landscapes for precise communications and healthcare access, working alongside the rest of the Prime Global group.read more >>
Prime Global is absolutely delighted to be listed in the top ten of the Alantra Pharma Fast 50; the third consecutive year we have been included in the top ten! This demonstrates and reinforces our sector-leading, sustainable organic growth.read more >>